Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Mei

Showing results (851-860 of 864) with videos related to

Pageof 87
Sort By:
Analytical Biochemistry|March 25, 2008
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitorsWen-Hsing Lin, Jen-Shin Song, Teng-Yuan Chang, et al.
Medicine|June 17, 2016
Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: First multicenter, cross-sectional studyYa Li, Hao Shi, Wei-Ming Wang, et al.
Clinical Science (London, England : 1979)|November 18, 2015
Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effectorJing Xu, Pei-Xue Li, Jun Wu, et al.
Nature Microbiology|March 20, 2026
LRP8 is a functional receptor for yellow fever virusMiao Mei, Yang Yang, Zihan Zhang, et al.
Leukemia & Lymphoma|September 16, 2015
Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasmsXing-Nong Ye, Xin-Ping Zhou, Ju-Ying Wei, et al.
Nature Neuroscience|June 14, 2016
Lrp4 in astrocytes modulates glutamatergic transmissionXiang-Dong Sun, Lei Li, Fang Liu, et al.
Muscle & Nerve|June 3, 2020
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter studyMichael H Rivner, Brandy M Quarles, Jin-Xiu Pan, et al.
Nature Communications|April 8, 2022
Modification of BRCA1-associated breast cancer risk by HMMR overexpressionFrancesca Mateo, Zhengcheng He, Lin Mei, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell functionAgata M Kieliszek, Erika Apel, Suky Zheng, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 18, 2014
Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trialLi Zhang, Ping Li, Chang-ying Xing, et al.
Pageof 87

Showing results (851-860 of 864) with videos related to

Sort By:
Pageof 87
Analytical Biochemistry|March 25, 2008
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitorsWen-Hsing Lin, Jen-Shin Song, Teng-Yuan Chang, et al.
Medicine|June 17, 2016
Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: First multicenter, cross-sectional studyYa Li, Hao Shi, Wei-Ming Wang, et al.
Clinical Science (London, England : 1979)|November 18, 2015
Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effectorJing Xu, Pei-Xue Li, Jun Wu, et al.
Nature Microbiology|March 20, 2026
LRP8 is a functional receptor for yellow fever virusMiao Mei, Yang Yang, Zihan Zhang, et al.
Leukemia & Lymphoma|September 16, 2015
Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasmsXing-Nong Ye, Xin-Ping Zhou, Ju-Ying Wei, et al.
Nature Neuroscience|June 14, 2016
Lrp4 in astrocytes modulates glutamatergic transmissionXiang-Dong Sun, Lei Li, Fang Liu, et al.
Muscle & Nerve|June 3, 2020
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter studyMichael H Rivner, Brandy M Quarles, Jin-Xiu Pan, et al.
Nature Communications|April 8, 2022
Modification of BRCA1-associated breast cancer risk by HMMR overexpressionFrancesca Mateo, Zhengcheng He, Lin Mei, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell functionAgata M Kieliszek, Erika Apel, Suky Zheng, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 18, 2014
Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trialLi Zhang, Ping Li, Chang-ying Xing, et al.
Pageof 87